News
Zacks Investment Research on MSN2d
Telix Shares May Gain on the Distribution Deal With Cardinal HealthTelix Pharmaceuticals TLX recently announced a major step in expanding access to its next-generation prostate cancer imaging ...
Cardinal Health (NYSE:CAH) has been selected as a distributor for Telix Pharmaceuticals' Gozellix®, an important development ...
Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...
Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...
Capital Brief on MSN5d
Telix Pharmaceuticals expects no 'material impact' from tariffsTelix Pharmaceuticals says it does not expect any material impact on its business or supply chain as a result of ...
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul ...
Stockhead on MSN4d
Health Check: Relax! Tariffs shape as the next Y2K as biotechs report ‘nothing to see here’As with the infamous Y2K computer bug, tariffs are shaping up largely as an irrelevance for US-exposed ASX biotechs.
Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces ...
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback